(1)
Ferkolj, I.; Ihan, A.; Markovic, S.; Veceric, Z.; Pohar, M. Infliximab Reduces the Number of Activated Mucosal Lymphocytes in Patients With Crohn’s Disease. JGLD 2006, 15, 231-235.